Metraipolis › archive › dc_fc353d501b0c
Therapeutic Drug Monitoring Versus Fixed-Interval Dosing of Dalbavancin in Implant-Associated Spinal Infections: Grand Round/A Case Study — Europe PMC PMID:40970606
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40970606
- DOI
- 10.1097/ftd.0000000000001386
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T21:07:48.966Z
- SHA-256 of the archived text
9d3e71e7dd4bbf434b76008ba8c102ec72d0a48d6960d4a14244406dae853c72- Stable URL of this page
https://metraipolis.com/documento/dc_fc353d501b0c
How to cite
Therapeutic Drug Monitoring Versus Fixed-Interval Dosing of Dalbavancin in Implant-Associated Spinal Infections: Grand Round/A Case Study — Europe PMC PMID:40970606 — Europe PMC (en), https://europepmc.org/article/MED/40970606 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc353d501b0c (Metraipolis archive dc_fc353d501b0c, sha256 9d3e71e7dd4bbf434b76008ba8c102ec72d0a48d6960d4a14244406dae853c72)
BibTeX
@misc{dcfc353d501b0c,
title = {Therapeutic Drug Monitoring Versus Fixed-Interval Dosing of Dalbavancin in Implant-Associated Spinal Infections: Grand Round/A Case Study — Europe PMC PMID:40970606},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40970606},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc353d501b0c; sha256 9d3e71e7dd4bbf434b76008ba8c102ec72d0a48d6960d4a14244406dae853c72},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40970606. Agents can read the archived copy with the MCP tool read_document.